The contribution of Latin American research to HPV epidemiology and natural history knowledge

Imagem de Miniatura
Arquivos
art_SICHERO_The_contribution_of_Latin_American_research_to_HPV_2020.PDF (150.46 KB)
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2020
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRAS DIVULG CIENTIFICA
Autores
PICCONI, M. A.
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.53, n.2, article ID e9560, 10p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Our aim was to review the major contributions of studies conducted in different Latin American (LA) countries to the field of human papillomavirus (HPV) epidemiology, natural history, risk of disease, and prevention strategies, mainly in the uterine cervix. Although cytological screening is established in several countries in LA, incidence and mortality rates from cervical cancer (CC) are still extremely high. Finally, data from large cohort studies conducted in LA countries provided seminal data to propose primary and secondary prevention modalities: the HPV vaccine has been introduced in the national immunization programs of several LA countries and multiple screening experiences using HPV testing are under evaluation in the region.
Palavras-chave
HPV, Latin America, Immunization, Cervical cancer, Natural history, Screening
URI
https://observatorio.fm.usp.br/handle/OPI/35435
Referências
  1. Alemany L, 2014, INT J CANCER, V135, P88, DOI 10.1002/ijc.28636
  2. Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757
  3. Amador-Molina A, 2013, J GEN VIROL, V94, P393, DOI 10.1099/vir.0.045807-0
  4. Berois N, 2014, J MED VIROL, V86, P647, DOI 10.1002/jmv.23870
  5. Berois N, 2013, INT J GYNECOL CANCER, V23, P527, DOI 10.1097/IGC.0b013e318285e753
  6. Berumen J, 2001, J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325
  7. Betiol JC, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0067-8
  8. BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514
  9. Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8
  10. Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321
  11. Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018
  12. Bzhalava D, 2015, VIROLOGY, V476, P341, DOI 10.1016/j.virol.2014.12.028
  13. Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403
  14. Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001
  15. Chan PKS, 2013, INT J CANCER, V132, P2528, DOI 10.1002/ijc.27932
  16. Chan PKS, 2011, J INFECT DIS, V203, P1565, DOI 10.1093/infdis/jir157
  17. Chen AA, 2015, J VIROL, V89, P10680, DOI 10.1128/JVI.01747-15
  18. Ciapponi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025493
  19. Claeys P, 2003, TROP MED INT HEALTH, V8, P704, DOI 10.1046/j.1365-3156.2003.01082.x
  20. Claeys P, 2002, SEX TRANSM INFECT, V78, P204, DOI 10.1136/sti.78.3.204
  21. Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12
  22. Curado MP, 2014, ANN GLOB HEALTH, V80, P370, DOI 10.1016/j.aogh.2014.09.009
  23. de Sanjose S, 2019, CURR OPIN VIROL, V39, P16, DOI 10.1016/j.coviro.2019.06.006
  24. de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8
  25. Deluca GD, 2012, MEDICINA-BUENOS AIRE, V72, P461
  26. deSanjose S, 1996, AM J PUBLIC HEALTH, V86, P1532, DOI 10.2105/AJPH.86.11.1532
  27. ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18
  28. Ferreccio C, 2004, CANCER EPIDEM BIOMAR, V13, P2271
  29. Ferreccio C, 2003, CANCER EPIDEM BIOMAR, V12, P815
  30. Ferrera A, 2000, INT J EPIDEMIOL, V29, P817, DOI 10.1093/ije/29.5.817
  31. Ferrera A, 1999, INT J CANCER, V82, P799, DOI 10.1002/(SICI)1097-0215(19990909)82:6<799::AID-IJC5>3.0.CO;2-5
  32. Flores R, 2006, INT J CANCER, V118, P1187, DOI 10.1002/ijc.21477
  33. Franzetti M, 2019, CURR HIV RES, V17, P1, DOI 10.2174/1570162X17666190327153038
  34. Giuliano A R, 2001, Rev Panam Salud Publica, V9, P172, DOI 10.1590/S1020-49892001000300007
  35. Gontijo RC, 2007, EUR J OBSTET GYN R B, V133, P239, DOI 10.1016/j.ejogrb.2006.05.012
  36. Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485
  37. GUERRERO E, 1992, J CLIN MICROBIOL, V30, P2951, DOI 10.1128/JCM.30.11.2951-2959.1992
  38. Herrero R, 2000, J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464
  39. HERRERO R, 1992, INT J EPIDEMIOL, V21, P1050, DOI 10.1093/ije/21.6.1050
  40. Herrero R, 1990, Bull Pan Am Health Organ, V24, P263
  41. Herweijer E, 2016, INT J CANCER, V138, P2867, DOI 10.1002/ijc.30035
  42. Hildesheim A, 2001, BRIT J CANCER, V84, P1219, DOI 10.1054/bjoc.2001.1779
  43. Hildesheim A, 2001, J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315
  44. Hindryckx P, 2006, SEX TRANSM INFECT, V82, P334, DOI 10.1136/sti.2006.019745
  45. Jeronimo J, 2016, J CLIN VIROL, V76, pS69, DOI 10.1016/j.jcv.2015.11.035
  46. Kasamatsu E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218016
  47. Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0
  48. Lajous M, 2005, CANCER EPIDEM BIOMAR, V14, P1710, DOI 10.1158/1055-9965.EPI-04-0926
  49. Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M
  50. Ludani S, 2008, INT J GYNECOL OBSTET, V101, P172, DOI 10.1016/j.ijgo.2007.11.013
  51. Maciag PC, 2002, J INFECT DIS, V186, P164, DOI 10.1086/341080
  52. Matos E, 2003, SEX TRANSM DIS, V30, P593, DOI 10.1097/01.OLQ.0000085181.25063.6C
  53. Mendoza L, 2013, INT J GYNECOL OBSTET, V122, P44, DOI 10.1016/j.ijgo.2013.01.020
  54. Mirabello L, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw100
  55. Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442
  56. Munoz N, 1996, JNCI-J NATL CANCER I, V88, P1068, DOI 10.1093/jnci/88.15.1068
  57. Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907
  58. Munoz N, 1996, SEX TRANSM DIS, V23, P504, DOI 10.1097/00007435-199611000-00012
  59. MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513
  60. Munoz N, 2009, BRIT J CANCER, V100, P1184, DOI 10.1038/sj.bjc.6604972
  61. Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013
  62. Nyitray AG, 2015, J INFECT DIS, V212, P202, DOI 10.1093/infdis/jiv061
  63. Ortiz-Ortiz J, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0242-3
  64. Perez G, 2008, INT J CANCER, V122, P1311, DOI 10.1002/ijc.23260
  65. Picconi MA, 2003, J MED VIROL, V69, P546, DOI 10.1002/jmv.10343
  66. Campbell CMP, 2015, CANCER PREV RES, V8, P190, DOI 10.1158/1940-6207.CAPR-14-0296
  67. Ramas V, 2013, J MED VIROL, V85, P845, DOI 10.1002/jmv.23479
  68. REEVES WC, 1989, NEW ENGL J MED, V320, P1437, DOI 10.1056/NEJM198906013202201
  69. Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249
  70. Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044
  71. Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0
  72. Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S
  73. Salmeron J, 2003, CANCER CAUSE CONTROL, V14, P505, DOI 10.1023/A:1024806707399
  74. Santos C, 2001, BRIT J CANCER, V85, P966, DOI 10.1038/sj.bjc.6691948
  75. Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328
  76. Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179
  77. Schlecht NF, 2003, J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037
  78. Sichero L, 2006, BRAZ J MED BIOL RES, V39, P707, DOI 10.1590/S0100-879X2006000600002
  79. Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481
  80. Sichero L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0677-y
  81. Sichero L, 2013, VIROLOGY, V443, P214, DOI 10.1016/j.virol.2013.04.024
  82. Tabora N, 2010, INT J GYNECOL CANCER, V20, P323, DOI 10.1111/IGC.0b013e3181d1c2f8
  83. Taylor S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1633-9
  84. Tonon SA, 2007, INT J INFECT DIS, V11, P76, DOI 10.1016/j.ijid.2006.01.002
  85. Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129
  86. Vaccarella S, 2006, INT J CANCER, V119, P1934, DOI 10.1002/ijc.21992
  87. Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959
  88. Villa LL, 2011, CANCER LETT, V305, P106, DOI 10.1016/j.canlet.2010.12.002
  89. Wendland EM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021170
  90. Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03